David Orlicky Selected Research

6-ethyl-24-norcholane-3,7,23-triol-23 sulfate

1/2018

FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Orlicky Research Topics

Disease

2	Fibrosis (Cirrhosis) 01/2019 - 01/2018
2	Obesity 01/2018 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2018
1	Infections 12/2023
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Fatty Liver 01/2019
1	Inflammation (Inflammations) 01/2019
1	Biliary Atresia 11/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Proteinuria 01/2018
1	Maternal Obesity 01/2014
1	Transitional Cell Carcinoma 06/2002
1	Squamous Intraepithelial Lesions 05/2002
1	Neoplasms (Cancer) 05/2002
1	Papillomavirus Infections 05/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2002
1	Uterine Cervical Dysplasia 05/2002

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 01/2019 - 01/2014
2	SurvivinIBA 06/2002 - 05/2002
1	Interleukin-17 (Interleukin 17)IBA 12/2023
1	oxidized low density lipoproteinIBA 01/2019
1	CholesterolIBA 01/2019
1	Dietary Fats (Dietary Fat)IBA 01/2019
1	CytokinesIBA 11/2018
1	Adenosine Diphosphate (ADP)IBA 01/2018
1	6-ethyl-24-norcholane-3,7,23-triol-23 sulfateIBA 01/2018
1	NAD (NADH)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	6alpha-ethyl-23(S)-methylcholic acidIBA 01/2018
1	Acetyl-CoA CarboxylaseIBA 01/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 06/2002
1	Inhibitor of Apoptosis ProteinsIBA 05/2002

Therapy/Procedure

1	Hysterectomy 05/2002